Bill
Bill > A116
NJ A116
NJ A116Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.
summary
Introduced
01/14/2020
01/14/2020
In Committee
01/14/2020
01/14/2020
Crossed Over
Passed
Dead
01/11/2022
01/11/2022
Introduced Session
2020-2021 Regular Session
Bill Summary
This bill requires a physician to offer to test a patient for dihydropyrimidine dehydrogenase deficiency prior to the patient undergoing chemotherapy. Dihydropyrimidine dehydrogenase deficiency is a disorder in which the human body experiences difficultly or is unable to breakdown chemotherapy drugs leading to a harmful reaction. Under the bill, health insurance plans in this State are to cover expenses incurred in conducting one test for dihydropyrimidine dehydrogenase deficiency every year.
AI Summary
This bill requires a physician to offer to test a patient for dihydropyrimidine dehydrogenase deficiency, a disorder that makes it difficult for the body to break down chemotherapy drugs, before the patient undergoes chemotherapy. The bill also mandates that health insurance plans in New Jersey cover the cost of one such test per year, as well as any necessary prescription drug treatment for the disorder, provided the plan covers prescription drugs.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Introduced, Referred to Assembly Health Committee (on 01/14/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2020/A116 |
| BillText | https://www.njleg.state.nj.us/Bills/2020/A0500/116_I1.HTM |
| Bill | https://www.njleg.state.nj.us/Bills/2020/A0500/116_I1.PDF |
| BillText | https://www.njleg.state.nj.us/2020/Bills/A0500/116_I1.HTM |
| Bill | https://www.njleg.state.nj.us/2020/Bills/A0500/116_I1.PDF |
Loading...